imipramine has been researched along with dimethylphenylpiperazinium iodide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, D; Weinstock, M | 1 |
McMorn, SO; Peers, C; Rana, B; Reeve, HL; Vaughan, PF; Wyatt, CN | 1 |
2 other study(ies) available for imipramine and dimethylphenylpiperazinium iodide
Article | Year |
---|---|
Tricyclic antidepressant drugs as antagonists of muscarinic receptors in sympathetic ganglia.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Cats; Clomipramine; Desipramine; Dimethylphenylpiperazinium Iodide; Ganglia, Autonomic; Ganglia, Spinal; Imipramine; Iprindole; Nictitating Membrane; Norepinephrine; Receptors, Cholinergic; Receptors, Muscarinic; Serotonin; Viloxazine | 1976 |
Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine.
Topics: Desipramine; Dimethylphenylpiperazinium Iodide; Electrophysiology; Humans; Imipramine; Ion Channels; Membrane Potentials; Nervous System Neoplasms; Neuroblastoma; Neurons; Nicotinic Antagonists; Tumor Cells, Cultured | 1993 |